Global Ursodeoxycholic Acid Drug Competitive Landscape Professional Research Report 2025
Description
Global Ursodeoxycholic Acid Drug Competitive Landscape Professional Research Report 2025
Research Summary
Ursodeoxycholic Acid (UDCA) as a drug refers to the medication containing the active pharmaceutical ingredient ursodeoxycholic acid. This bile acid is used therapeutically for its ability to dissolve cholesterol-based gallstones, preventing their formation and promoting their elimination. Additionally, Ursodeoxycholic Acid is employed in the treatment of certain liver conditions, including primary biliary cholangitis, where it exhibits hepatoprotective effects. The drug is typically administered orally, commonly in the form of tablets or capsules, and its use is directed by healthcare professionals based on the specific medical condition being addressed. Ursodeoxycholic Acid plays a vital role in managing gallstone-related issues and liver disorders, offering a pharmacological approach to improve patient outcomes.
According to DIResearch's in-depth investigation and research, the global Ursodeoxycholic Acid Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Ursodeoxycholic Acid Drug include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Humanwell, Mitsubishi Tanabe Pharma, Lannett, Mylan, Bruschettini, Impax, Shanghai Pharma, Grindeks etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Ursodeoxycholic Acid Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ursodeoxycholic Acid Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Ursodeoxycholic Acid Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ursodeoxycholic Acid Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Ursodeoxycholic Acid Drug Include:
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Humanwell
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Ursodeoxycholic Acid Drug Product Segment Include:
Capsule Drug
Tablet Drug
Ursodeoxycholic Acid Drug Product Application Include:
Primary Biliary Cirrhosis(PBC)
Gallstones
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Ursodeoxycholic Acid Drug Industry PESTEL Analysis
Chapter 3: Global Ursodeoxycholic Acid Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Ursodeoxycholic Acid Drug Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Ursodeoxycholic Acid Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Ursodeoxycholic Acid Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Ursodeoxycholic Acid Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Ursodeoxycholic Acid Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Ursodeoxycholic Acid Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Ursodeoxycholic Acid Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Ursodeoxycholic Acid Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Ursodeoxycholic Acid Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Ursodeoxycholic Acid Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Ursodeoxycholic Acid Drug Product by Type
- 1.2.1 Capsule Drug
- 1.2.2 Tablet Drug
- 1.3 Ursodeoxycholic Acid Drug Product by Application
- 1.3.1 Primary Biliary Cirrhosis(PBC)
- 1.3.2 Gallstones
- 1.3.3 Others
- 1.4 Global Ursodeoxycholic Acid Drug Market Revenue and Sales Analysis
- 1.4.1 Global Ursodeoxycholic Acid Drug Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Ursodeoxycholic Acid Drug Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Ursodeoxycholic Acid Drug Market Sales Price Trend Analysis (2020-2032)
- 1.5 Ursodeoxycholic Acid Drug Industry Trends and Innovation
- 1.5.1 Ursodeoxycholic Acid Drug Industry Trends and Innovation
- 1.5.2 Ursodeoxycholic Acid Drug Market Drivers and Challenges
- 2 Ursodeoxycholic Acid Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Ursodeoxycholic Acid Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Ursodeoxycholic Acid Drug Market Analysis by Regions
- 4.1 Ursodeoxycholic Acid Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Ursodeoxycholic Acid Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Ursodeoxycholic Acid Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Ursodeoxycholic Acid Drug Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Ursodeoxycholic Acid Drug Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Ursodeoxycholic Acid Drug Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Ursodeoxycholic Acid Drug Sales Forecast by Region (2026-2032)
- 4.4 Global Ursodeoxycholic Acid Drug Sales Price Trend Analysis (2020-2032)
- 5 Global Ursodeoxycholic Acid Drug Market Size by Type and Application
- 5.1 Global Ursodeoxycholic Acid Drug Market Size by Type
- 5.1.1 Global Ursodeoxycholic Acid Drug Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Ursodeoxycholic Acid Drug Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Ursodeoxycholic Acid Drug Market Size by Application
- 5.2.1 Global Ursodeoxycholic Acid Drug Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Ursodeoxycholic Acid Drug Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Ursodeoxycholic Acid Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Ursodeoxycholic Acid Drug Market Size by Type
- 6.3.1 North America Ursodeoxycholic Acid Drug Sales by Type (2020-2032)
- 6.3.2 North America Ursodeoxycholic Acid Drug Revenue by Type (2020-2032)
- 6.4 North America Ursodeoxycholic Acid Drug Market Size by Application
- 6.4.1 North America Ursodeoxycholic Acid Drug Sales by Application (2020-2032)
- 6.4.2 North America Ursodeoxycholic Acid Drug Revenue by Application (2020-2032)
- 6.5 North America Ursodeoxycholic Acid Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Ursodeoxycholic Acid Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Ursodeoxycholic Acid Drug Market Size by Type
- 7.3.1 Europe Ursodeoxycholic Acid Drug Sales by Type (2020-2032)
- 7.3.2 Europe Ursodeoxycholic Acid Drug Revenue by Type (2020-2032)
- 7.4 Europe Ursodeoxycholic Acid Drug Market Size by Application
- 7.4.1 Europe Ursodeoxycholic Acid Drug Sales by Application (2020-2032)
- 7.4.2 Europe Ursodeoxycholic Acid Drug Revenue by Application (2020-2032)
- 7.5 Europe Ursodeoxycholic Acid Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Ursodeoxycholic Acid Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Ursodeoxycholic Acid Drug Market Size by Type
- 8.3.1 China Ursodeoxycholic Acid Drug Sales by Type (2020-2032)
- 8.3.2 China Ursodeoxycholic Acid Drug Revenue by Type (2020-2032)
- 8.4 China Ursodeoxycholic Acid Drug Market Size by Application
- 8.4.1 China Ursodeoxycholic Acid Drug Sales by Application (2020-2032)
- 8.4.2 China Ursodeoxycholic Acid Drug Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Ursodeoxycholic Acid Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Ursodeoxycholic Acid Drug Market Size by Type
- 9.3.1 APAC (excl. China) Ursodeoxycholic Acid Drug Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Ursodeoxycholic Acid Drug Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Ursodeoxycholic Acid Drug Market Size by Application
- 9.4.1 APAC (excl. China) Ursodeoxycholic Acid Drug Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Ursodeoxycholic Acid Drug Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Ursodeoxycholic Acid Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Ursodeoxycholic Acid Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Ursodeoxycholic Acid Drug Market Size by Type
- 10.3.1 Latin America Ursodeoxycholic Acid Drug Sales by Type (2020-2032)
- 10.3.2 Latin America Ursodeoxycholic Acid Drug Revenue by Type (2020-2032)
- 10.4 Latin America Ursodeoxycholic Acid Drug Market Size by Application
- 10.4.1 Latin America Ursodeoxycholic Acid Drug Sales by Application (2020-2032)
- 10.4.2 Latin America Ursodeoxycholic Acid Drug Revenue by Application (2020-2032)
- 10.5 Latin America Ursodeoxycholic Acid Drug Market Size by Country
- 10.6 Latin America Ursodeoxycholic Acid Drug Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Ursodeoxycholic Acid Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Ursodeoxycholic Acid Drug Market Size by Type
- 11.3.1 Middle East & Africa Ursodeoxycholic Acid Drug Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Ursodeoxycholic Acid Drug Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Ursodeoxycholic Acid Drug Market Size by Application
- 11.4.1 Middle East & Africa Ursodeoxycholic Acid Drug Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Ursodeoxycholic Acid Drug Revenue by Application (2020-2032)
- 11.5 Middle East Ursodeoxycholic Acid Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Ursodeoxycholic Acid Drug Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Ursodeoxycholic Acid Drug Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Ursodeoxycholic Acid Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Ursodeoxycholic Acid Drug Average Sales Price by Manufacturers (2021-2025)
- 12.2 Ursodeoxycholic Acid Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Ursodeoxycholic Acid Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Dr. Falk Pharma
- 13.1.1 Dr. Falk Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Portfolio
- 13.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Daewoong Pharmaceutical
- 13.2.1 Daewoong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Portfolio
- 13.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Teva
- 13.3.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Teva Ursodeoxycholic Acid Drug Product Portfolio
- 13.3.3 Teva Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Humanwell
- 13.4.1 Humanwell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Humanwell Ursodeoxycholic Acid Drug Product Portfolio
- 13.4.3 Humanwell Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Mitsubishi Tanabe Pharma
- 13.5.1 Mitsubishi Tanabe Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Portfolio
- 13.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Lannett
- 13.6.1 Lannett Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Lannett Ursodeoxycholic Acid Drug Product Portfolio
- 13.6.3 Lannett Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Mylan
- 13.7.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Mylan Ursodeoxycholic Acid Drug Product Portfolio
- 13.7.3 Mylan Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Bruschettini
- 13.8.1 Bruschettini Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Bruschettini Ursodeoxycholic Acid Drug Product Portfolio
- 13.8.3 Bruschettini Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Impax
- 13.9.1 Impax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Impax Ursodeoxycholic Acid Drug Product Portfolio
- 13.9.3 Impax Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Shanghai Pharma
- 13.10.1 Shanghai Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Shanghai Pharma Ursodeoxycholic Acid Drug Product Portfolio
- 13.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Grindeks
- 13.11.1 Grindeks Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Grindeks Ursodeoxycholic Acid Drug Product Portfolio
- 13.11.3 Grindeks Ursodeoxycholic Acid Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Ursodeoxycholic Acid Drug Industry Chain Analysis
- 14.2 Ursodeoxycholic Acid Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Ursodeoxycholic Acid Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Ursodeoxycholic Acid Drug Typical Downstream Customers
- 14.4 Ursodeoxycholic Acid Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
